Medical News

New Generation Super-Mini Percutaneous Nephrolithotomy Effective and Safe in Treatment of Large Renal Stone

A new retrospective study confirmed the efficacy and safety of new generation super-mini percutaneous nephrolithotomy (New-SMP) in the treatment of...

15 Feb, 2019

Email this page
Glucose Tolerance and Triglycerides Improve in Hypogonadal Men on 5-Year Testosterone Replacement Therapy

The 5-year testosterone replacement therapy (TRT) improved the levels of fasting blood sugar (FBS), hemoglobin A1c (HbA1c) and triglycerides (TG) in...

05 Feb, 2019

Email this page
Pre-Treatment Serum Total Testosterone Level, A Predictor of Improvement in Bladder Outlet Obstruction with Tadalafil

The pre-treatment total serum testosterone (TT) levels could independently predict the improvement in bladder outlet obstruction (BOO) in patients...

30 Jan, 2019

Email this page
Asthmatic Male Patients at a Higher Risk of Developing BPH than Those without Asthma

A recent retrospective nationwide study conducted in Taiwan concluded that the risk of developing benign prostatic hyperplasia (BPH) was higher in...

17 Jan, 2019

Email this page

Key Trials

Efficacy of Intravesical Instillation of Onabotulinum Toxin A in Overactive Bladder and Interstitial Cystitis/Bladder Pain Syndrome is Limited

A systematic review and meta-analysis concluded that intravesical instillation of onabotulinum toxin-A (OBTX-A) had limited efficacy with...

Early Use of Vacuum Therapy Has an Excellent Therapeutic Effect in Men undergoing Radical Prostatectomy

Early use of vacuum therapy significantly improved the erectile dysfunction and penile shrinkage in men post radical prostatectomy (RP) and enhanced...

Survival Outcomes with Extended and Limited Lymph Node Dissection in Bladder Cancer Patients undergoing Radical Cystectomy

A recent prospective study concluded that the extended lymph node dissection (LND) in bladder cancer patients undergoing radical cystectomy did not...

Enzalutamide and Abiraterone Improved Survival Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer

Enzalutamide was the most effective in prolonging the progression-free survival,  followed by abiraterone and tasquinimod in patients with...

Slide Library

Tadalafil (Tadaflo)

Erectile dysfunction (ED) and the signs and symptoms of benign prostatic hyperplasia (BPH), are prevalent disorders in middle-aged and older men...

Email this page
Cranberry + D-mannose (Cranfit)

Around 50% of women experience at least one episode of UTI at some point in their lifetime and recurrent UTI occur in about 20-40% of women....

Email this page
Management of Advanced Prostate Cancer: Current Concepts

Prostate cancer has become a major public health burden worldwide and its incidence rates are increasing in India.  Hormonal therapy or androgen...

Email this page
Solifenacin succinate (Soliact)

The overall prevalence of overactive bladder (OAB) in men and women over the age of 40 years is 16.6%. Anticholinergic therapy is currently a...

Email this page

Our Publications

Excerpts From: AUA Annual Meeting 2011

This booklet provides key abstracts from American Urological Association (AUA) Annual meeting 2011 held in Washington, D.C USA.

Patient Education

All You Wanted to Know about Prostate Cancer

Prostate is one of the most common cancers in men. This material describes risk factors, symptoms, diagnosis and treatment of prostate cancer. Also...

Urinary Stones

This patient education article provides a brief overview on the incidence, causes, risk factors, types of urinary stones and symptoms, diagnosis as...

Know the Facts about UTI

This patient education leaflet provides a brief overview on the incidence, causes, risk factors, symptoms, diagnosis and treatment of urinary tract...

Understanding Kidney Stone Disease

This poster provides information on the sites and types of urinary stones as well as the different treatment options available for the management of...


Explore >>

Currently there is no content under this category.


Which testosterone preparation do you prefer in your patients with late onset hypogonadism?
Testosterone Cypionate/Enanthate
17% (1 vote)
Testosterone undecanoate injection
50% (3 votes)
Testosterone decanoate + testosterone isocaproate + testosterone phenpropionate + testosterone propionate injection
17% (1 vote)
Oral testosterone undecanoate
17% (1 vote)
Testosterone gel
0% (0 votes)
Total votes: 6